🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The SEC appears to be dropping its investigation into Illumina -- scoop from Jared Whitlock $ILMN endpts.com/sec-expected-t…

SEC expected to drop investigation of Illumina’s $8B Grail deal endpts.com/sec-expected-t…

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices Good reporting from Max Bayer and Drew Armstrong endpts.com/drugmakers-to-…

'Find a way, or make one': How two scientists hope to revitalize CRISPR's rare disease crisis Good piece from Ryan Cross the Science Boss on efforts from Fyodor Urnov and others endpts.com/crispr-isnt-li…

Illumina said the SEC has closed its investigation into the company’s $8 billion purchase of Grail, confirming Endpoints News reporting earlier this week. endpts.com/illumina-confi…

😊The Endpoints News newsroom has TWO finalists for the NIHCM trade awards! Nice to see the great work of John Carroll + Jared Whitlock recognized nihcm.org/awards/trade-j…

Big one from Shelby Livingston out today Endpoints News -- the result of a monthslong investigation

🏆~Another~ big congrats to the Endpoints News team for two more awards! This time two win's at the SIIA Neal awards, for Andrew Dunn + our health tech team Lydia Ramsey Pflanzer Shelby Livingston + Ngai Yeung!!!

I'm late to the party but don't miss this investigation from Shelby Livingston into Empower, a compounding pharmacy that produces weight loss medications and other drugs. endpts.com/pharmacy-empow…

Post-Hoc: AI's CRISPR moment Both technologies are powerful and hold vast potential. But the AI bio field should learn lessons from the overhyped history of CRISPR in how its leaders set expectations: endpts.com/post-hoc-ai-bi…

🪙You've heard of the PayPal Mafia. 🧬Now meet the Illumina-ti $ILMN endpts.com/how-illuminas-…

DNA giant Illumina spawned an ecosystem. Now its former employees are both its customers and fiercest competitors. Latest, via Endpoints News endpts.com/how-illuminas-…

🧬Meet the Illumina-ti: The DNA giant's alumni have founded more than 70 companies and raised $5.2 billion in VC. Some are customers, others rivals — all reshaping the genomics world Illumina helped create. endpts.com/how-illuminas-…

Meet the FDA staff "fired" by DOGE and left in limbo:

The man at the center of DOGE's health care cuts has quite the history: Top execs from a startup he founded feel he ripped them off & lower-level workers say their jobs were to cut services from vulnerable patients. shorturl.at/Y7d7m via STAT

FDA chief Makary told Sen. Hawley this week that he’s “committed” to reviewing the abortion pill mifepristone, marking the clearest pledge to look into the drug since his confirmation hearing endpoints.news/makary-tells-h…

NEW: A trio of young MIT scientists say their new AI model has made progress in predicting binding affinity, a key property in drug discovery Good affinity prediction has evaded other AI models, but Boltz-2 showed solid improvement: endpoints.news/mit-scientists…

Bill says, "Vaccines have saved millions of lives, while also causing enormous harm to some." Hundreds of millions of lives, Bill. "Enormous harm to some." - How vague and weak that sounds in comparison.